Tenecteplase.
- Published in:
- Formulary, 2000, v. 35, n. 8, p. 647
- By:
- Publication type:
- Article
Works matching IS 1082801X AND DT 2000 AND VI 35 AND IP 8
Results: 14
1
2
News Capsules.
- Published in:
- Formulary, 2000, v. 35, n. 8, p. 641
- Publication type:
- Article
3
FDA Drug Approvals.
- Published in:
- Formulary, 2000, v. 35, n. 8, p. 627
- Publication type:
- Article
4
Cost-effectiveness analysis of interferon alpha-2b with ribavirin for chronic hepatitis C infection.
- Published in:
- 2000
- By:
- Publication type:
- Journal Article
5
Acute renal failure: overview of current and potential therapies.
- Published in:
- 2000
- By:
- Publication type:
- Journal Article
6
Treatment of motor complications in advancing Parkinson's disease: which drugs and when?
- Published in:
- 2000
- By:
- Publication type:
- Journal Article
7
Tenecteplase: a novel fibrin-specific thrombolytic agent for treatment of acute myocardial infarction.
- Published in:
- 2000
- By:
- Publication type:
- Journal Article
8
Drug Watch.
- Published in:
- Formulary, 2000, v. 35, n. 8, p. 700
- Publication type:
- Article
9
Policymakers move to expand Medicare drug benefit, Rx-to-OTC switch process.
- Published in:
- Formulary, 2000, v. 35, n. 8, p. 698
- By:
- Publication type:
- Article
10
ASHP Pearls.
- Published in:
- Formulary, 2000, v. 35, n. 8, p. 690
- Publication type:
- Article
11
Drug Use Issues and Actions.
- Published in:
- Formulary, 2000, v. 35, n. 8, p. 696
- Publication type:
- Article
12
Cost-effectiveness analysis of interferon alpha-2b with ribavirin for chronic hepatitis C infection.
- Published in:
- Formulary, 2000, v. 35, n. 8, p. 681
- By:
- Publication type:
- Article
13
Acute renal failure: Overview of current and potential therapies.
- Published in:
- Formulary, 2000, v. 35, n. 8, p. 669
- By:
- Publication type:
- Article
14
Treatment of motor complications in advancing Parkinson's disease: Which drugs and when?
- Published in:
- Formulary, 2000, v. 35, n. 8, p. 654
- By:
- Publication type:
- Article